Introduction
After the Liberalization, Mergers and Acquisitions have acquired a new dimension in the Indian Economy. The implementation of economic reforms in many countries created various kinds of opportunities by way of mergers and acquisitions in the international scenario.
Various firms in India have taken up the restructuring activities to sell off non-core businesses and concentrating on achieving core-competencies.
In India, Mergers and Acquisitions have emerged to be the utmost effectual way of corporate restructuring and also become an integral part of the long-standing business stratagem of firms.
Basant (2000) opined that Economic Liberalization of 1990s and associated opening up of the Indian Economy changed the nature of oligopolistic environment in the form of Mergers and Acquisitions for restructuring of corporate assets.
Synergy is the key factor influencing mergers, where the value of the combined firm is significantly more as compared to the aggregate value of the individual firms. As a result, if they are to stay independent, the combination of two firms will yield a more valuable entity than the summation of values of the two firms - Value (A + B) > Value (A) + Value (B)
In Indian context, it has been observed that during the first period of liberalisation, more than 50% of Mergers and 74% of Acquisitions were horizontal due to market share enhancement and consolidation of existing product market. About 16% of mergers and 41% of acquisitions were vertical and the rest were all conglomerate in nature.
Survey of the Literature
Vyas, Narayanan and Ramanathan (2012) analyse in their research paper that Mergers and Acquisitions in pharmaceutical industry and its elements in the context of a developing country.
Their findings suggests that small firm are unable to expand due to limited availability of resources, at the same time larger firms have resources to invest on multiple capacity expansion as well as technological expansion. The results show that research and development expenditure for the industry as a whole is just 2.6% and minimum is zero.
Therefore, to survive in the competitive scenario, pharmaceutical firms required high amount of investment to continue production by way of continuous upgradation of technology and capital assets.
As per Gupta and Mishra (2013) Mergers and Acquisitions can generate synergies and economies of scale by way of magnifying processes and reducing overheads and the investors makes it clear that the above idea can provide augmented market power.
However, Mergers and Acquisitions have to be augmented with the regulatory compliance in the country where it takes place. Rani, Yadav and Jain (2013) in their study compares about the performance of the firm involved in their study, before and after Mergers and Acquisitions.
The study indicates that Mergers and Acquisitions apparently are beneficial for the buying firms in the long-run with regard to their operating performance. The findings indicate that profitability of buying firms have improved in the post event era.
Singh (2013) tries to capture the performance of 20 Public Limited Companies listed on the Stock Exchange through the comparison of financial ratios. Change in the financial leverage of the companies is one of the parameters which was considered in the study.
In his study, it shows that, there was a significant increase in the mean operating profit margin, net profit margin ratios, return on net worth and return on capital employed after the merger. Bhalla (2014) focussed on recent trends of Mergers and Acquisitions in various Indian sectors.